NEWSROOM
April 19, 2019
Innosuisse approved a grant for SunRegen Healthcare AG’s innovation project (Innosuisse funding application no. 35796.1 IP-LS). The total value of this project is CHF 1 million to facilitate the collaboration with EPFL and UZH
SunRegen Healthcare AG is a biopharmaceutical company to develop drugs for the unmet medical needs of Neurodegenerative diseases and ophthalmic diseases.
SunRegen Healthcare AG
Business Parc Reinach
Christoph Merian-Ring 11, 4153 Reinach Switzerland
Copyright © 2025, SunRegen Healthcare AG